Tags: eli | lilly | earnings | sales

Lilly's Quarterly Sales, Profit Fall Short of Estimates

Wednesday, 24 Oct 2012 06:51 AM

Eli Lilly and Co. reported quarterly earnings and sales below Wall Street expectations, hurt by higher taxes and generic competition for its Zyprexa schizophrenia drug.

The company said on Wednesday that it had earned $1.33 billion, or $1.18 per share, in the third quarter. That compared with $1.24 billion, or $1.11 per share, in the year-earlier period.

Excluding special items, Lilly earned 79 cents per share. Analysts on average expected 83 cents, according to Thomson Reuters I/B/E/S.

Revenue fell 11 percent to $5.44 billion, below Wall Street expectations of $5.62 billion.

© 2017 Thomson/Reuters. All rights reserved.

1Like our page
2Share
Companies
Eli Lilly and Co. reported quarterly earnings and sales below Wall Street expectations, hurt by higher taxes and generic competition for its Zyprexa schizophrenia drug.The company said on Wednesday that it had earned $1.33 billion, or $1.18 per share, in the third quarter....
eli,lilly,earnings,sales
91
2012-51-24
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved